Kennesaw State University mechanical engineering professor Philippe Sucosky has earned a prestigious American Heart Association (AHA) Institutional Enhancement Award to advance his study on bicuspid ...

Middle-aged adults who need an aortic valve replacement fare better with mechanical devices than with the valves made from animal tissues that they currently most often receive, U.S. researchers ...

offering hope to patients who may have limited treatment options.” Aortic stenosis, a severe and life-threatening condition, occurs when the aortic valve narrows, restricting blood flow from the ...

The current treatment of AS consists of surgical ... cells into an osteoblast phenotype, which causes aortic valve fibrosis and calcification (sclerosis) and eventually hemodynamic obstruction ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

device designed for aortic regurgitation (AR), by late 2025. This approval will mark a significant step forward, expanding TAVR’s treatment indications to include AR — a condition previously ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality. Despite advancements in emergency interventions, the optimal treatment ...

The coexistence of transthyretin cardiac amyloidosis (ATTR‐CA) and aortic stenosis (AS ... or prescription claims for related treatment. Inclusion in the AS–plus–ATTR‐CA cohort required that patients ...